Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample Preferential transmission of the MAO-A 941G allele to affected children.код для вставкиСкачать
American Journal of Medical Genetics Part B (Neuropsychiatric Genetics) 134B:110 –114 (2005) Association Analysis of the Monoamine Oxidase A and B Genes With Attention Deficit Hyperactivity Disorder (ADHD) in an Irish Sample: Preferential Transmission of the MAO-A 941G Allele to Affected Children Katharina Domschke,1,2 Karen Sheehan,1 Naomi Lowe,1 Aiveen Kirley,1 Celine Mullins,1 Roderick O’Sullivan,1 Christine Freitag,3 Tim Becker,3 Judith Conroy,1 Michael Fitzgerald,1 Michael Gill,1 and Ziarih Hawi1* 1 Departments of Genetics and Psychiatry, Trinity College Dublin, Ireland Department of Psychiatry, University of Muenster, Germany 3 Department of Child and Adolescent Psychiatry, University of Saarland, and Institute for Medical Biometry, Informatics, and Epidemiology, University of Bonn, Germany 2 Pharmacological and genetic studies suggest the importance of the dopaminergic, serotonergic, and noradrenergic systems in the pathogenesis of attention deficit hyperactivity disorder (ADHD). Monoamine oxidases A and B (MAO-A and MAO-B) degrade biogenic amines such as dopamine and serotonin and thereby control the levels of these neurotransmitters in the central nervous system. We examined four polymorphisms in the MAO-A gene (30 bp promoter VNTR, CA microsatellite in intron 2, 941G/T SNP in exon 8, and A/G SNP in intron 12) as well as two markers in the MAO-B gene (CA microsatellite in intron 2 and T/C SNP in intron 13) for association with ADHD in an Irish sample of 179 nuclear families. TDT analysis of the examined MAO-A markers revealed a significant association of the more active MAO-A 941G allele with the disorder (x2 ¼ 5.1, P ¼ 0.03, OR ¼ 1.7). In addition, haplotype analysis revealed a significantly increased transmission of a haplotype consisting of the shorter allele of the promoter VNTR (allele 1), the 6-repeat allele of the CA microsatellite and the G-allele of the 941G/T SNP (famhap global statistic 34.54, P ¼ 0.01) to ADHD cases. No significant distortion in the number of transmitted alleles was observed between the two examined MAO-B polymorphisms and ADHD. These findings suggest the importance of the 941G/T MAO-A polymorphism in the development of ADHD at least in the Irish population. ß 2005 Wiley-Liss, Inc. Grant sponsor: Health Research Board, Dublin (to K.S., N.L., and A.K.); Grant sponsor: Wellcome Trust; Grant sponsor: Dublin Molecular Medicine Centre (to Z.H.); Grant sponsor: Heinrich– Hertz–Stiftung (to K.D.); Grant sponsor: Hyperactive and Attention Disorder (HAD) Group Ireland. *Correspondence to: Dr. Ziarih Hawi, Department of Genetics, Trinity College Dublin, Dublin 2, Ireland. E-mail: email@example.com Received 31 August 2004; Accepted 9 November 2004 DOI 10.1002/ajmg.b.30158 ß 2005 Wiley-Liss, Inc. KEY WORDS: attention deficit hyperactivity disorder; monoamine oxidase A; monoamine oxidase B; TDT; Xchromosome INTRODUCTION Attention deficit hyperactivity disorder (ADHD) is one of the most common behavioral disorders affecting 2%–6% of schoolaged children worldwide [Tannock, 1998]. It is characterized by inattention, hyperactive, and impulsive behavior leading to difficulty organizing tasks, excessive motor activity and risk taking behavior. Although the aetiology of ADHD is not fully understood, a strong genetic component in the pathogenesis of the disease with an estimated heritability of 70%–90% has been reported [Levy et al., 1997]. Several lines of evidence have implicated the dopaminergic, noradrenergic, and serotonergic systems in the development of ADHD. Monoamine oxidase A (MAO-A) is an enzyme that degrades biogenic amines such as dopamine, noradrenaline, adrenaline, and serotonin by oxidative deamination and thereby plays a key role in the modification of signal transduction in these neurotransmitter systems [Shih and Thompson, 1999]. In addition, MAO-A inhibitors such as tranylcypromine have been shown to be effective in the pharmacological treatment of ADHD [Zametkin et al., 1985]. Furthermore, MAO-A has also been reported to be involved in the pathogenesis of the intermediate phenotypes ‘‘impulsivity’’ and ‘‘aggression’’. Brunner et al.  described a rare point mutation in the MAO-A gene associated with loss of function, which resulted in a highly impulsive and aggressive behavioural phenotype. Moreover, MAO-A knockout mice have been observed to exhibit a significantly increased aggressive behavior accompanied by elevated levels of serotonin, noradrenaline, and dopamine [Cases et al., 1995]. Finally, maltreated children with a genotype conferring high levels of MAO-A expression were reported to be less likely to develop antisocial problems [Caspi et al., 2002]. In children with ADHD, significantly lower levels of platelet MAO-A activity associated with increased impulsivity and inattention were reported [Shekim et al., 1986]. These findings indicate that MAO-A is a good candidate gene for ADHD and that DNA variations in this gene may play a role in the predisposition to the disorder. The gene maps to chromosome Xp11.4-p11.3. A functionally relevant 30 bp VNTR has been Association Analysis of the MAO-A and B Genes and ADHD Genes identified in the promoter region of the MAO-A gene [Sabol et al., 1998]. The longer alleles (3a, 4, and 5) have been shown to affect the transcription of the gene three to four times more efficiently than the shorter allele 3 [Deckert et al., 1999]. Significant association between the longer alleles of the VNTR and ADHD has been observed [Manor et al., 2002], but could not be replicated in an independent study [Lawson et al., 2003]. The short allele has been reported to be associated with impulsivity and aggression [Manuck et al., 2000], which was confirmed in a subgroup of patients with ADHD and broadly defined concurrent conduct disorder [Lawson et al., 2003]. Another functional variant, a silent 941G/T polymorphism in exon 8 has been reported to be associated with low (941T) and high (941G) MAO-A activity, respectively [Hotamisligil and Breakefield, 1991]. However, a recent study did not find any association of this polymorphism with either ADHD in general or a subgroup of patients with ADHD and broadly defined concurrent conduct disorder [Lawson et al., 2003]. Finally, a CA-repeat microsatellite located in intron 2 [Black et al., 1991] was reported to be associated with ADHD in a Chinese sample [Jiang et al., 2001]. This has been supported by similar findings describing a trend towards preferential transmission of the 122 bp allele of the CA(n) microsatellite, which, however, is not the same allele that Jiang et al. reported to be linked with the disease [Payton et al., 2001]. Monoamine oxidase B (MAO-B) catalyzes the oxidative deamination of neurotransmitters such as dopamine, phenylethylamine, and benzylamine. Additionally, pharmacological studies provide preliminary evidence for a beneficial effect of monoamine oxidase B inhibitors such as selegiline or deprenyl in the treatment of ADHD [Feigin et al., 1996; Akhondzadeh et al., 2003]. Administration of deprenyl has also been shown to significantly reduce impulsiveness in an animal model of ADHD [Boix et al., 1998]. Thus, the MAO-B gene was regarded as a good candidate gene for ADHD. The gene coding for MAOB maps to chromosome Xp11.23 in close proximity to the MAOA gene. The MAO-A and MAO-B genes are functionally related to each other by exhibiting an identical exon-intron organization as well as a high sequence similarity [Grimsby et al., 1991]. A CA-repeat polymorphism in intron 2 of the MAO-B gene (rs3838196) has been analyzed in a Chinese sample with ADHD, but was not found to be associated with the disorder [Jiang et al., 2001]. Additionally, a single nucleotide T/C polymorphism (rs1799836) in intron 13 has been reported as a possible risk factor for Parkinson disease [Costa et al., 1997], but to date has not yet been examined in relation to ADHD. 111 In the present study, we attempted to assess the importance of the above-mentioned three variants at the MAO-A locus in a sample of 179 Irish ADHD nuclear families. Furthermore, we also examined an additional MAO-A marker in an effort to conduct linkage disequilibrium and haplotype analysis of the studied markers. We also examined two markers at the MAO-B locus for possible association/linkage with ADHD. MATERIALS AND METHODS Subjects The Irish clinical ADHD sample comprising 179 nuclear families was recruited from child psychiatric clinics and schools in West County Dublin and from the Hyperactive and Attention Deficit Children’s Support Group of Ireland. Further details on the sample used in the present study can be found in Kirley et al. . Genotyping DNA was extracted from whole blood using standard phenol chloroform procedure or from buccal cells as described in Daly et al. . Fragments containing the respective polymorphisms were amplified by PCR on a PTC-225 Peltier Thermocycler (MJ Research, Dublin, Ireland) and subsequently genotyped using the conditions given in Table I. The two microsatellite markers (MAO-A CA(n) and MAO-B CA(n) (rs3838196)) were genotyped using the semi automated florescent method on an ABI 3100 DNA sequencer (ABI Applied Biosystems, Warrington, UK). Statistical Analysis For single marker analysis, we used the transmission disequilibrium test (TDT) [Spielman et al., 1993]. The McNemar w2 test was used to assess the significance level. For the analysis of multi-allelic markers, we applied the ETDT (TDTPHASE v2.40) [Dudbridge, 2003]. Since MAO-A and MAO-B are x-linked markers, genotype information from fathers was only used in the analysis of female patients with ADHD. Linkage disequilibrium (LD) between the markers expressed as D0 was assessed by means of the GOLD program (www.well.ox.ac.uk/asthma/gold). Only parents’ (in female probands) and mothers’ (in male probands) genotypes were used to assess LD. Hardy–Weinberg equilibrium was TABLE I. PCR and Genotyping Conditions for the Examined MAO-A and MAO-B Markers Primer (50 –30 ) MAO-A 30 bp VNTR CA(n) repeat 94IG/T A/G (rs979605) MAO-B T/C (rs1799836) CA(n) repeat (rs3838196) F: CCCAGGCTGCTCCAGAAAC R: GGACCTGGGCAGTTGTGC F: AGAGACTAGACAAGTTGCAC R: CACTATCTTGTTAGCTCACT F: GACCTTGACTGCCAAGAT R: CTTCTCCTTCCAGAAGGCC F: GCTGCTACACGGCCTACTTC R: AGAAATGGGGATTTTGACAAC F(T): CACTGGCAAATAGCAAAAGT F(C): CACTGGCAAATAGCAAAAGC R: GGATTTACTTTGCAGGCACC F: GTGTTGGTGTGAAGGAAGCA R: GATTGAGTAAGAGGGAAATGG Annealing temperature (8C) Restriction enzyme 56 — Deckert et al.  56 — Black et al.  54 Fnu4HI 64 TspRI 64 — 64 — Reference Hotamisligil and Breakefield  — Costa et al.  — w2 ¼ 0, df ¼ 1, P ¼ 1.0 w2 ¼ 0.2, df ¼ 1, P ¼ 0.71 w2 ¼ 5.1, df ¼ 1, P ¼ 0.03* LRS ¼ 10.8, df ¼ 7, P ¼ 0.15 9 0 20 9 4 18 34 11 7 2 27 2 4 15 42 6 w2 ¼ 0.9, df ¼ 1, P ¼ 0.39 48 39 As in previous studies [Manor et al., 2002; Lawson et al., 2003], due to their functional roles [Deckert et al., 1999] the alleles of the MAO-A 30 bp VNTR were grouped into two classes (3 allele vs. all longer alleles (3a, 4, and 5) and named allele 1 and 2, respectively. Alleles 3 and 4, however, in concordance with other studies constituted over 95% of all observed alleles. Eight alleles were detected, which were name according to fragment length from 1 (longest) through 8 (shortest). c Twelve alleles were detected, which were named according to fragment length from 1 (longest) through 12 (shortest). Only eight of these alleles, however, were found to be transmitted from heterozygous mothers. *Significant P-value at a significance level of 0.05. b a 47 47 47 47 941G/T 1 (T) 2 (G) 26 45 45 26 1 (A) 2 (G) 35 31 31 35 1 (T) 2 (C) T/C (rs1799836) A/G(rs979605) T Marker alleles NT CA(n) 1 2 3 4 5 6 7 8 NT T Marker allelesc NT NT Marker alleles T MAO-B T Marker alleles NT T 39 48 1(3) 2(3a,4,5) DISCUSSION In the present study, we conducted TDT analysis on four markers in the MAO-A gene, three of which have been previously analyzed for association with ADHD in several different studies [Jiang et al., 2001; Payton et al., 2001; Manor et al., 2002; Lawson et al., 2003]. The examined markers are spaced about 20 kb along the MAO-A gene. Significant linkage/ 30 bp VNTR No difference in the transmission of T or C alleles of the MAO-B rs1799836 marker to affected children was observed (Table II). ETDT analysis performed on the CA(n) (rs3838196) marker showed a slight, but insignificant increase in the transmission of allele 3 (Table II). D0 analysis showed no evidence for LD between the two markers (D0 ¼ 0.27, P ¼ 0.2). Marker allelesb MAO-B NT MAO-A TDT analysis conducted on all examined markers of the MAO-A gene (Table II) showed significantly higher transmission of the more active 941G allele (allele 2) to ADHD cases as compared to the lower active 941T allele (allele 1) (transmitted: 45, not transmitted: 26; w2 ¼ 5.1, P ¼ 0.03, OR ¼ 1.7). Additionally, stratifying the sample for parental history of ADHD, an increased transmission of the more active 941G allele from parents with a positive history for ADHD was observed (transmitted: 26, not transmitted: 13; w2 ¼ 4.3, P ¼ 0.06). None of the remaining examined markers showed any significant distortion in the transmission to ADHD cases. LD measured as D0 among the MAO-A markers was significant between all examined markers (Table III) with D0 ranging between 0.63 and 0.85. Haplotype analysis using a two-marker window revealed a significantly increased transmission of a haplotype containing the shorter 3 allele of the 30 bp VNTR (allele 1) and allele 6 of the CA-repeat (transmitted: 24, not transmitted: 11; famhap global statistic: 24.86, P ¼ 0.05). This association was further enhanced when a three-marker window (including the 941G/T) was analyzed. A haplotype comprising allele 1 of the 30 bp VNTR, allele 6 of the CA-repeat and the 941G allele (allele 2) was preferentially transmitted to ADHD cases (transmitted: 14, not transmitted: 5; famhap global statistic: 34.54, P ¼ 0.01). T The distribution of genotypes (from parents with no history of ADHD) for all examined markers did not significantly differ from those expected according to the Hardy–Weinberg equilibrium. Marker allelesa RESULTS MAO-A examined using the online site (http://kursus.kvl.dk/shares/ vetgen/_Popgen/genetik/applets/kitest.htm). Haplotype analysis was carried out using the program FAMHAP (version 14) [Becker and Knapp, 2004]. In this program, an expectation maximization (EM) algorithm is implemented to estimate transmitted and nontransmitted haplotype frequencies. The test statistic is computed from the table of transmitted and nontransmitted haplotypes. FAMHAP is unique in taking the smallest P-value found among the combinations as test statistic. The transmission/nontransmission status is then permuted to obtain the distribution of the test statistic. The empirical P-value is the fraction of permutation replicates resulting in a test statistic greater than or equal to the test statistics of the real data. The program was run on genotypes from 170 parent child trios, where genotype information for all four MAO-A SNPs was obtainable. For families with a male proband, transmitted and nontransmitted haplotypes of the mother only were used. Statistical analyses were not corrected for multiple testing. CA(n) (rs3838196) 1 0 0 2 5 10 3 37 27 4 23 23 5 25 34 6 17 17 7 8 5 8 1 0 9 0 0 10 1 1 11 0 0 12 0 0 LRS ¼ 5.8, df ¼ 7, P ¼ 0.56 Domschke et al. TABLE II. Frequencies and Statistical Analysis of Transmitted (T) and Not Transmitted (NT) Alleles of MAO-A and MAO-B Markers to ADHD Cases 112 Association Analysis of the MAO-A and B Genes and ADHD Genes 0 TABLE III. Linkage Disequilibrium Analysis (Measured as D ) Between the Examined MAO-A Markers Marker 1 30 bp VNTR 30 bp VNTR 30 bp VNTR CA(n) repeat CA(n) repeat 941G/T Marker 2 w2 P-value D0 CA(n) repeat 941G/T A/G (rs979605) 941G/T A/G (rs979605) A/G (rs979605) 145.2 70.7 88.9 105.5 127.3 153.1 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.746 0.630 0.709 0.690 0.758 0.853 association between ADHD and the more active MAO-A 941G allele was observed, as it was the case for a haplotype containing the 941G allele. Evidence arising from functional imaging, genetic and biochemical studies point towards a hypodopaminergic state in the pathogenesis of ADHD [Solanto, 2002]. The increased frequency of the more active MAO-A 941G allele in ADHD can be explained on the basis that elevated MAO-A activity would result in a higher turnover and thereby decreased levels of dopamine, which possibly contributes to the dopamine deficit proposed for ADHD. Besides degrading dopamine, MAO-A is additionally involved in the metabolic degradation of serotonin (5-HT), which has also been implicated in the pathogenesis of ADHD. Peripheral measures of blood serotonin as well as central 5-HT function have been reported to be reduced in children with ADHD [Kruesi et al., 1990; Spivak et al., 1999]. Also, there is some evidence that serotonin agonists such as fluoxetine might be effective in the pharmacological treatment of ADHD [Gainetdinov et al., 1999]. A higher activity variant of MAO-A generating a higher serotonin turnover would be likely to exacerbate serotonin deficiency in ADHD and thereby increase the susceptibility to the disorder. Furthermore, although the MAO-A 941G/T polymorphism is functional, it is possible that the observed association results from another functional variant within the coding region or the boundaries of the MAO-A gene. However, the present study failed to confirm previous studies reporting positive linkage/association results of ADHD with the longer, higher activity alleles of the MAO-A 30 bp VNTR [Manor et al., 2002] and the MAO-A CA(n) microsatellite [Jiang et al., 2001; Payton et al., 2001]. An explanation for these diverging findings could be populationspecific genetic heterogeneity as reflected by a Chinese study reporting strong evidence for association of ADHD with the DXS7 marker closely linked to the MAO-A gene [Jiang et al., 2000], which, however, could not be confirmed in an Irish study [Lowe et al., 2001]. Additionally, applying a TDT design in the investigation of x-chromosomal markers such as MAO-A and MAO-B restricts the use of informative transmissions to heterozygous mothers only. This decreases the statistical power and thereby increases the risk of false negative results. In this case, as suggested by Manor et al.  a case-controlbased approach might be of additional value. With regard to the MAO-B gene, the present study confirms previous reports of no linkage/association of the MAO-B CA(n) microsatellite (rs3838196) in a Chinese sample of patients with ADHD [Jiang et al., 2001]. Additionally, we did not observe association of MAO-B rs1799836 with the disorder suggesting no major influence of the examined MAO-B markers on the pathogenesis of ADHD at least in the Irish population. In conclusion, the findings of the present study indicate that the higher activity variant of the monoamine oxidase A (941G) might be a risk factor in the development of ADHD. This is in keeping with the hypodopaminergic and/or hyposerotonergic hypothesis of the pathogenesis of the disorder. In the future, it will be of interest to investigate the role of this marker by using intermediate- or endophenotypes such as electrophysiological 113 markers, functional neuroimaging or performance on neuropsychological tasks. ACKNOWLEDGMENTS We would also like to thank the families that participated in the study. REFERENCES Akhondzadeh S, Tavakolian R, Davari-Ashtiani R, Arabgol F, Amini H. 2003. Selegiline in the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 27:841–845. Becker T, Knapp M. 2004. A powerful strategy to account for multiple testing in the context of haplotype analysis. Am J Hum Genet 75:561–570. Black GCM, Chen ZY, Craig IW, Powell JF. 1991. Dinucleotide repeat at the MAOA locus. Nucleic Acid Res 19:689. Boix F, Qiao SW, Kolpus T, Sagvolden T. 1998. Chronic L-deprenyl treatment alters brain monoamine levels and reduces impulsiveness in an animal model of attention-deficit hyperactivity disorder. Behav Brain Res 94:153–162. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. 1993. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262:578–580. Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S, Műller U, Aguet M, Babinet C, Chen Shih J, De Maeyer E. 1995. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268:1763–1766. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R. 2002. Role of genotype in the cycle of violence in maltreated children. Science 297:851–854. Costa P, Checkoway H, Levy D, Smith-Weller T, Franklin GM, Swanson PD, Costa LG. 1997. Association of a polymorphism in intron 13 of the monoamine oxidase B gene with parkinson disease. Am J Med Genet 74:154–156. Daly G, Hawi Z, Fitzgerald M, Gill M. 1999. Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 4:192–196. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, DiBella D, Noethen MM, Maffei P, Franke P, Fritze J, Maier W, Propping P, Beckmann H, Bellodi L, Lesch KP. 1999. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621–624. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25:115–221. Feigin A, Kurlan R, McDermott MP, Beach J, Dimitsopulos T, Brower CA, Chapieski L, Trinidad K, Como P, Jankovic J. 1996. A controlled trial of deprenyl in children with Tourette’s syndrome and attention deficit hyperactivity disorder. Neurology 46:965–968. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG. 1999. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397–401. Grimsby J, Chen K, Wang LJ, Lan NC, Shih JC. 1991. Human monoamine oxidase A and B genes exhibit identical exon–intron organization. Proc Natl Acad Sci USA 88:3637–3641. Hotamisligil GS, Breakefield XO. 1991. Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 49:383–392. Jiang S, Xin R, Wu X, Lin S, Qian Y, Ren D, Tang G, Wang D. 2000. Association between attention deficit hyperactivity disorder and the DXS7 locus. Am J Med Genet 96:289–292. Jiang S, Xin R, Lin S, Qian Y, Tang G, Wang D, Wu X. 2001. Linkage studies between attention-deficit hyperactivity disorder and the monoamine oxidase genes. Am J Med Genet 105:783–788. Kirley A, Lowe N, Mullins C, McCarron M, Daly G, Waldman I, Fitzgerald M, Gill M, Hawi Z. 2004. Phenotype studies of the DRD4 gene polymorphisms in ADHD: Association with oppositional defiant disorder and positive family history. Am J Med Genet (Neuropsychiatry Genet) 15; 131B(1):38–42. Kruesi MJ, Papoport JL, Hamburger S, Hibbs E, Potter WZ, Lenane M, Brown GL. 1990. Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. Arch Gen Psychiatry 47:419–426. 114 Domschke et al. deficit hyperactivity disorder: A family-based study. Am J Med Genet 105:464–470. Lawson DC, Turic D, Langley K, Pay HM, Govan CF, Norton N, Hamshere ML, Owen MJ, O’Donovan MC, Thapar A. 2003. Association analysis of monoamine oxidase A and attention deficit hyperactivity disorder. Am J Med Genet 116:84–89. Sabol SZ, Hu S, Hamer D. 1998. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103:273–279. Levy F, Hay DA, McStephen M, Wood C, Waldman I. 1997. Attentiondeficit hyperactivity disorder: A category of a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 36:737–744. Shekim WO, Bylund DB, Alexson J, Glaser RD, Jones SB, Hodges K, Perdue S. 1986. Platelet MAO and measures of attention and impulsivity in boys with attention deficit disorder and hyperactivity. Psychiatry Res 18: 179–188. Lowe N, Hawi Z, Fitzgerald M, Gill M. 2001. No evidence of linkage or association between ADHD and DXS7 locus in Irish population. Am J Med Genet 105:394–395. Shih JC, Thompson RF. 1999. Monoamine oxidase in neuropsychiatry and behavior. Am J Hum Genet 65:593–598. Manor I, Tyano S, Mel E, Eisenberg J, Bachner-Melman R, Kotler M, Ebstein RP. 2002. Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): Preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). Mol Psychiatry 7:626–632. Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506–516. Manuck SB, Flory JD, Ferrell RE, Mann JJ, Muldoon MF. 2000. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res 95:9–23. Payton A, Holmes J, Barrett JH, Hever T, Fitzpatrick H, Trumper AL, Harrington R, McGuffin P, O’Donovan M, Owen M, Ollier W, Worthington J, Thapar A. 2001. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention- Solanto MV. 2002. Dopamine dysfunction in AD/HD: Integrating clinical and basic neuroscience research. Behav Brain Res 130:65–71. Spivak B, Vered Y, Yoran-Hegesh R, Averbuch E, Mester R, Graf E, Weizman A. 1999. Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorder. Acta Psychiatr Scand 99:300–304. Tannock R. 1998. Attention deficit hyperactivity disorder: Advances in cognitive neurobiological and genetics research. J Child Psychol Psychiatry 39:65–99. Zametkin A, Rapoport JL, Murphy DL, Linnoila M, Ismond D. 1985. Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy. Arch Gen Psychiatry 42:962–966.